NEW DELHI (India CSR): In an era where corporate responsibility is paramount, GlaxoSmithKline Pharmaceuticals Limited (GSK India) stands as a beacon of profound social commitment, showcasing its dedication to enhancing the lives of millions across the nation. For the financial year ended March 31, 2025, the pharmaceutical giant channeled a remarkable Rs 16.04 crore into diverse Corporate Social Responsibility (CSR) initiatives, significantly exceeding its statutory obligation of Rs 1,601.93 lakhs. This substantial investment underscores GSK India’s unwavering belief that true progress is inextricably linked to healthy, empowered communities, driving their ‘Ahead Together’ ambition for society and the planet.
Table: GSK India CSR FY2025
| Parameter | Details |
|---|---|
| Company Name | GlaxoSmithKline Pharmaceuticals Limited (GSK India) |
| Financial Year | FY 2025 |
| Total CSR Obligation | Rs 16.02 crore |
| Total CSR Spent | Rs 16.04 crore |
| Excess CSR Spend | Rs 1.91 lakhs |
| Administrative Overheads | Rs 80.10 lakhs |
| Impact Assessment Expenditure | Rs 1.95 lakhs |
| Flagship Disease Elimination Initiative | Lymphatic Filariasis (LF) |
| Albendazole Tablets Supplied (FY25) | 3.3 crore |
| Cumulative Albendazole Tablets Supplied | 398 crore |
| Education Initiative | GSK Scholars Programme |
| Scholarship Support | Rs 1,00,000 annually for 4.5 years |
| Medical Scholars Benefited | 425 students |
| Smart Classrooms Installed | 100 (across India) |
| Students Benefited (Smart Classrooms) | 35,000+ |
| Child Cancer Care Support Partner | St. Jude India Childcare Centres |
| Families Supported in FY25 | 145 |
| Volunteering Hours by Employees | 8,708 hours |
| Employee Volunteering Activities | 123 activities |
| Other Notable Initiatives | Menstrual hygiene, LGBTQIA+ health, tree plantation, plastic waste management |
| Sustainability Recognition | BusinessWorld India – Most Sustainable Pharma Company |
| CSR Governance | CSR Committee led by Dr. (Ms.) S. Maheshwari (Chairperson) |
| Vision Alignment | ‘Viksit Bharat 2047’ – Self-reliant, developed India |
| Tagline | “Ahead Together” |
A Legacy of Dedication to Public Health
GSK India’s century-long presence in India has been marked by a deep-rooted commitment to public health. Their CSR policy is strategically aligned with national priorities and key UN Sustainable Development Goals, focusing intently on healthcare, education, and broader community development. This robust framework ensures that every rupee spent aims to create measurable, long-term impact for vulnerable populations, moving beyond mere compliance to genuine societal contribution.
Championing Disease Elimination: The Fight Against Lymphatic Filariasis
A cornerstone of GSK India’s healthcare initiatives is its relentless pursuit of eliminating Lymphatic Filariasis (LF), a debilitating disease causing severe pain and disfigurement. For over two decades, the company has partnered with the World Health Organization (WHO) and the Indian government, contributing significantly to India’s ambitious target of eliminating LF by 2027 – three years ahead of the global goal. In FY2025 alone, GSK India supplied 3.3 crore albendazole tablets, bringing their cumulative contribution to an astounding 398 crore tablets to date. This monumental effort highlights a sustained dedication to a healthier, disease-free India, an impact that has been voluntarily assessed and summarized in a dedicated report.
Empowering the Next Generation: Education for a Brighter Future
Recognizing the transformative power of education, GSK India invests strategically in nurturing India’s educational ecosystem. The flagship GSK Scholars Programme provides crucial financial assistance, up to Rs 1,00,000 annually for 4.5 years, to meritorious yet financially challenged students pursuing medical careers. To date, this initiative has supported 425 medical scholars, paving the way for a new generation of healthcare professionals across 20 states. Furthermore, in collaboration with Yuva Unstoppable, GSK India inaugurated its 100th smart classroom in Nashik, part of a program that has already benefited over 35,000 students. These digitally equipped classrooms are revolutionizing learning experiences, reducing absenteeism, and preparing students for a digitally-driven future.
Holistic Care for Vulnerable Communities
Beyond large-scale programs, GSK India’s CSR efforts extend to providing compassionate care for vulnerable groups. Their partnership with St. Jude India Childcare Centres offers a ‘Home Away from Home’ for children battling cancer and their families, providing essential support including accommodation, nutritious meals, emotional assistance, and access to education during treatment. In the past year, this vital support was expanded to a second center, increasing its reach to 145 families. Additionally, initiatives focused on maternal and child health, such as addressing child nutrition in Mumbai and building awareness on ante and post-natal care in Kolkata, further exemplify GSK India’s holistic approach to community well-being.
Beyond the Core: Diverse Interventions and Employee Engagement
GSK India’s commitment to social impact is multifaceted, encompassing a wide array of interventions. These include vital programs on menstrual hygiene awareness, school sanitation, tree plantation, and even initiatives promoting healthcare access for LGBTQIA+ communities. The company’s focus on sustainability, being recognized as the most sustainable company in the pharmaceutical and healthcare sector by BusinessWorld India, further integrates with its CSR vision through efforts like water basin restoration and plastic waste management. A unique aspect of GSK India’s CSR is the active involvement of its employees. Through the ‘Together Day’ volunteering initiative, employees contributed 8,708 volunteering hours to 123 diverse activities, fostering a culture of health equity and community support from within.
Financial Stewardship and Compliance
The company’s CSR activities are executed with meticulous financial oversight. Out of the total spend of Rs 16.04 crore, administrative overheads accounted for Rs 80.10 lakhs, and impact assessment costs were Rs 1.95 lakhs. The excess spend of Rs 1.91 lakhs beyond the statutory obligation highlights GSK India’s proactive approach to social investment. The CSR Committee, comprising independent directors like Dr. (Ms.) S. Maheshwari (Chairperson) and key management personnel including Mr. B. Akshikar, ensures stringent compliance with Section 135 of the Companies Act, 2013, and relevant rules. Their latest Secretarial Audit Report confirms no qualifications, reservations, or adverse remarks regarding CSR compliance, reflecting robust governance in these critical areas.
You Learn: Building a Self-Reliant India
As GSK India steps into its second century of operations, its renewed optimism and confidence are fueled by a strategic vision to be a salient contributor to India’s rapidly evolving pharmaceutical landscape.
Aligned with the government’s ‘Viksit Bharat 2047’ initiative for a developed and self-reliant India, GSK India is dedicated to enhancing healthcare access and driving innovation in next-generation therapies. As Bhushan Akshikar, Managing Director of GlaxoSmithKline Pharmaceuticals Limited, articulated, “This vision, embodied in the mission ‘Viksit Bharat 2047,’ reflects our drive to make high-quality, accessible healthcare a reality for every region of the country. Together, we are working ‘Bharat Ke Liye,’ [For India] with the aim of meeting the demands of India’s diverse healthcare landscape and ensuring that healthcare is not just accessible but highest on quality standards”.
The significant CSR investment in FY2025 is not just a reflection of past success but a powerful testament to their enduring legacy of resilience and unwavering commitment to delivering high-quality healthcare solutions to millions across the country, building a healthier ‘Bharat’ (India) for all.
(India CSR)
